6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 1g

2,5,8,11,14-Pentaoxahexadecan-16-amine, 98%, 10g

2,4,6-Trichloropyrimidin-5-ol, 5g

2-(2-Bromopyridin-4-yl)-1-(pyridin-2-yl)ethanone, 95%, 100mg

(R)-5,5-Diphenyl-2-methyl-3,4-propano-1,3,2-oxazaborolidine>97.0%(T)5g

6-Methyl-1H-pyrrolo[3,2-b]pyridine, 97.0%, 250mg

3-Bromo-4-fluoro-1H-pyrrolo[2,3-b]pyridine, 97%, 5g

4'-Formylbiphenyl-4-carboxylic acid, 95.0%, 25g

N-METHYL-1H-IMIDAZOLE-5-CARBOXAMIDE, 98.0%, 100mg

1-(2-Nitrophenyl)piperidin-2-one, 98%, 100mg

(S)-tert-butyl 2-(4-(3-ethylureido)phenyl)-4-(3-methylmorpholino)-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate, 98%, 500mg

2,2-DIMETHYL-6-NITRO-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE, 95.0%, 5g

Decahydroisoquinoline (cis- and trans- mixture, predominantly cis-isomer)>98.0%(GC)25mL